HDB vs VRTX Comparison

HDFC Bank Ltd company engaged in providing a range of banking and financial services including retail banking, wholesale banking and treasury operations. Its segments are Treasury, Retail banking, Wholesale banking, and Other banking Operations. Majority of incomes if from Retail Banking which consists of digital banking segment which represents business by Digital Banking Units (DBUs) of the Bank. The said DBUs serves retail customers through the Bank's digital network and other online channels; and Non-Digital Banking which serves retail customers through the Bank's branch network and other channels. The bank generates majority of income from Domestic market. Its products are Personal Loan, Car Loan, Business Loan, Two Wheeler Loan, Gold Loan, Home Loan, Pre-Verified Properties, etc.

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is focused on diversifying its portfolio through Casgevy (gene-editing therapy for beta thalassemia and sickle-cell disease), Journavx (non-opioid pain drug for moderate-to-severe acute pain), and Palsonify (for acromegaly). Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases, cell therapies to deliver a functional cure for type 1 diabetes, povetacicept (for IgA nephropathy).